Pharma Pulse: Foundayo’s Historic FDA Approval and the Strategic Risk of Pharmacy Data Consolidation

Apr 02, 10:00 AM
Headliner
Share
Subscribe

In Pharma Pulse, Foundayo’s record 50-day FDA approval and the threat of pharmacy data consolidation to independent pharmacies.

Share
Subscribe
Next
Pharma Pulse: Shionogi's $2.5B Radicava Acquisition and the Industry Monitors U.S.-Iran Conflict for Supply Disruptions
Top episodes
Overcoming Supply Chain Challenges
by Pharma Pulse
Incorporating AI into Commercialization Plans
by Pharma Pulse
The Capabilities of a 3PL Provider
by Pharma Pulse